MDA-supported researchers have conducted a study of the perceived effects of congenital and childhood-onset type 1 myotonic dystrophy on those with the disorder
posted on August 28, 2013 - 9:55am
Communication difficulties, social role limitations, problems with mobility and walking, and cognitive impairment were the most frequently mentioned themes in open-ended interviews conducted with people affected by congenital-onset or childhood-onset type 1 myotonic muscular dystrophy (MMD1, or DM1) or their parents.
A small-molecule compound counteracts some of the effects of abnormal genetic instructions in MMD1
posted on November 3, 2009 - 10:00pm
A compound that has the potential to be refined and modified into a treatment for type 1 myotonic dystrophy (MMD1, or DM1) has been identified by researchers at the University of Oregon in Eugene, and the University of Rochester (N.Y.) School of Medicine and Dentistry.
Neuromuscular diseases can cause a variety of symptoms other than muscle weakness. Some people may feel their muscles are stiff or don't respond quickly; others might complain of cramps or twitches; while still others get tired quickly during exercise.
Not all of these symptoms are painful, but some can be inconvenient or annoying. Learning the medical names and natures of these symptoms can...